2022
Modeling environment through a general exposome factor in two independent adolescent cohorts
Moore T, Visoki E, Argabright S, Didomenico G, Sotelo I, Wortzel J, Naeem A, Gur R, Gur R, Warrier V, Guloksuz S, Barzilay R. Modeling environment through a general exposome factor in two independent adolescent cohorts. Exposome 2022, 2: osac010. PMID: 36606125, PMCID: PMC9798749, DOI: 10.1093/exposome/osac010.Peer-Reviewed Original ResearchExposome factorsOverall psychopathologyAdolescent cohortPubertal developmentEnvironmental exposuresAdvanced pubertal developmentSex-matched sampleKey health-related outcomesHealth-related outcomesCognitive Development StudyAdolescent Brain Cognitive Development (ABCD) studyGeneral healthCohortPhiladelphia Neurodevelopmental CohortConsistent associationABCD studyObesityNeurodevelopmental CohortParental educationExposurePsychopathologyFactorsPhysical environmental stimuli
2020
Resilience in psychosis spectrum disorder
Pries L, Guloksuz S, Rutten B. Resilience in psychosis spectrum disorder. 2020, 476-484. DOI: 10.1093/med/9780190653279.003.0053.Peer-Reviewed Original ResearchPsychosis spectrum disordersSpectrum disorderPsychological growthResilience factorsResilience researchFuture research directionsProtective factorsSocial factorsResilienceResearch directionsDifferent time pointsProspective studyDisordersAdversityLife spanTime pointsFirst evidenceResearchVulnerabilitySwift recoverySpanIllnessFactors
2011
P03-79 - How do european psychiatry trainees prescribe when treating depression, and what influences decision-making? (Survey of the European Federation of Psychiatric Trainees Research Group)
Jauhar S, Guloksuz S, Marques J, Nawka A, Roventa C, Psaras R, Andlauer O, Lydall G, De Vriendt N, Mendonca L, Van Zanten J, Dumiterscu I, Nwachukwu I, Riese F, Group E. P03-79 - How do european psychiatry trainees prescribe when treating depression, and what influences decision-making? (Survey of the European Federation of Psychiatric Trainees Research Group). European Psychiatry 2011, 26: 1248. DOI: 10.1016/s0924-9338(11)72953-4.Peer-Reviewed Original ResearchSide effect profileClinical practiceChoice of antidepressantSevere depressive episodeAntidepressant medicationDepressive episodeTreatment choiceResponse rateAntidepressantsSimilar antidepressantsSubsequent guidelinesPatientsEvidence baseMinimum response rateGuideline suggestionsRecent evidenceMedicationsEuropean traineesPsychiatry traineesEfficacyLittle evidenceSample sizeTraineesFactorsRecent literature
2010
P03-343 - Treatment choice in psychiatry? How would European trainees treat psychosis for their patients and themselves, and what influences decision-making?
Jauhar S, Guloksuz S, Marques J, Bendix M, Lydall G, Andlauer O, Gerber S, Roventa C, Van Zanten J, De Vriendt N, Nawka A, Nwachukw I, Dobrzynska E, Mufic A, Nazaraliev A, Dumitrescu I, Mendonca L, Riese F, Group E. P03-343 - Treatment choice in psychiatry? How would European trainees treat psychosis for their patients and themselves, and what influences decision-making? European Psychiatry 2010, 25: 958. DOI: 10.1016/s0924-9338(10)70949-4.Peer-Reviewed Original ResearchFirst-line therapySide effect profileTreatment choiceClinical practicePsychiatric clinical practiceEuropean traineesCATIE trialAntipsychotic medicationAntipsychoticsResponse ratePatientsEvidence baseMinimum response ratePsychosisRecent evidenceClozapineTherapyEfficacySample sizeTraineesPsychiatryMedicationsPrescribingFactorsResponders